Overexpression of PRMT7-V2 significantly promotes the growth of colorectal cancer cells and xenograft tumors, with the selective PRMT7 inhibitor SGC3027 exerting antitumor effects on human colorectal cancer cells. Here, PRMT7 is linked to colorectal cancer.